DSCR10

Across TCGA pan-cancer cohorts, DSCR10 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of DSCR10’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where DSCR10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DSCR10 is over-expressed in tumor.

BRCA are the cancer types where DSCR10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DSCR10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.023	.034	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

DSCR10–BRCA

Open the BRCA breakdown →